Our POWERbreathe Medic device receives approval for prescription in the UK by the NHS after rigorous assessment for clinical evidence, patient compliance and financial savings. The assessment finds it offers an evidence-based, drug-free treatment for patients with dyspnoea, especially those with asthma, COPD and heart failure.

Also, our POWERbreathe R&D team implements the latest in technology and research into the new POWERbreathe Plus IMT series, with new hi-tech design, optimised airflow performance, anti-bacterial qualities and other design developments.